Clin2
NCT05126914Possibly a fitRecruiting

Follow-up study for rare epilepsy in children

EpilepsyWest SyndromeDravet Syndrome

Part of Brain & nervous system clinical trials.

This study follows children and teens with rare forms of epilepsy to better understand their condition over time in real-life care. It may help doctors improve future care plans and support for families.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
Up to 15 years
Study type
Observational

Who can take part

  • You have a rare epilepsy diagnosis (a specific rare-disease code is used).
  • A parent or legal guardian involved in medical decisions agrees to participate.
  • The child is already being followed at one of the study’s participating hospital centers.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07251673Recruiting
Study of Dravet syndrome in children with SCN1A gene changes

This study follows children with Dravet syndrome caused by a specific SCN1A gene change to understand how the condition develops over time. It may help families know more about what to expect.

Paris, Ap-hp / DRCI
NCT06201897Recruiting· Phase 2/Phase 3
Brain excitability in West syndrome using magnetic stimulation

This trial studies brain electrical activity in children with West syndrome (infantile spasms) using a safe, non-invasive magnetic stimulation technique. It tests how the brain responds before and after starting ACTH or a ketogenic diet, which are standard treatments for infantile spasms.

New Delhi, National Capital Territory of Delhi
NCT06504511Recruiting
SCN1A gene study for epilepsy patients in the UK

This study aims to better understand SCN1A-related epilepsies by following patients over time. Researchers hope to learn more about how the condition progresses to help develop future treatments.

Glasgow
NCT05469373Recruiting
Testing ESIS for children with hard-to-treat epilepsy

This trial studies ESIS in children and teens (ages 1 to 30) who have epilepsy that has not been controlled by medications. It may help by improving how doctors evaluate and treat seizures, especially when an additional brain-monitoring test is planned.

Cincinnati, Ohio
NCT06660394Recruiting· Phase 3
LP352 for Dravet syndrome in children and adults

This study tests a new medicine called LP352 for children and adults with Dravet syndrome. It compares the study drug to a placebo (a pill with no medicine) to see if it helps reduce seizures.

Little Rock, Arkansas
NCT05651204Recruiting
Study of brain GABA signals in Dravet syndrome

This study looks at “GABA signals” in the body/brain to learn more about Dravet syndrome and how it may relate to seizures. If you have Dravet syndrome caused by a specific SCN1A gene change, you may be asked to provide genetic test results and help with study visits so researchers can compare biomarker readings.

Fort Worth, Texas

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.